Applied Filters:
Keyword:'153439-40-8'
Topic
Content Type
Collections
Topic Area
Applications
Product Category
153439-40-8
Showing 1-10 of 723 results for "153439-40-8" within Site Content
TSCA 8 Notification
Submit notification of unreported health effect
Solvent Analysis for 40 Per and Polyfluoroalkyl Substances
Trace-level PFAS analysis of solvents using SPE and LC-MS/MS to verify purity, method performance, and suitability for regulatory testing workflows.
Color Determination of Sugar Based on ICUMSA method GS9-8
Discover the ICUMSA® method GS9-8 (2011) to determine the color of sugar solutions with color indices ranging from 10 to 16 000 IU.
Recovery of PFAS via OTM-45 Using PFAS Resin
Ready-to-use Supelpak™-2 4PFAS resin shows no background contamination and reliable recovery of 40 PFAS for LC-MS/MS emission and air monitoring compliance.
Gold Nanorod Synthesis
Plasmonic nanoparticles have unique optical properties that can be tailored to suit a variety of applications in the biotechnology1–8 and electronics9–16 industries.
Summer Sale Promo - Cell Culture
Spend your summer accelerating your Cell Culture research.
Now through July 29, save up to 40% off our most popular Cell Culture products
Milli-Q® CLX 8Series Water Purification System for Clinical Analyzers
Target 99% uptime with the innovative Milli-Q® CLX 8Series water system. Reliable, high-quality water for analyzers. Advanced digital support.
Chromolith® WidePore 300 HPLC Columns
Analytical Chromolith® HPLC columns for Bio applications, 300A mesopores: RP-18, RP-8, RP-4, Prot-A, Epoxy
Famciclovir Tablets USP Monograph Method Using a Purospher™ STAR RP-8 endcapped HPLC Column and UV Detection
Following the new USP monograph for Famciclovir Tablets, Purospher™ STAR RP-8 endcapped HPLC columns can be used to monitor organic impurities in Famciclovir tablet formulations. Famciclovir is an antiviral drug indicated for the treatment of herpes zoster, herpes simplex virus
Life Science Business of Merck KGaA, Darmstadt, Germany Study: mRNA Technology a ‘Game Changer’ for Asia-Pacific Vaccine Manufacturers
According to a recent study sponsored by the Life Science business of Merck KGaA, Darmstadt, Germany, mRNA technology is a “game-changer” for Asia-Pacific (APAC) vaccine manufacturers. Nearly 40 manufacturers participated in the survey.
Page 1 of 73